Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aaron Ondrey currently holds 128,173 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Ondrey has been a net seller of MRTX stock. They have purchased $0 and sold $4.3K worth of shares.
Aaron Ondrey's most recent insider trade was on Jul 3, 2025, when they sold 1,477 shares at $2.88 per share.
Aaron Ondrey serves as Executive at Mirati Therapeutics, Inc. (MRTX). They have executed 11 insider transactions totaling $4.3K over their tenure at the company.
Aaron Ondrey holds the position of Executive at Mirati Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Aaron Ondrey has shown a selling trading pattern, with $0 in total purchases and $4.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Aaron Ondrey was on Dec 29, 2023, when they purchased $1000.0K worth of MRTX shares. This transaction involved 17,021 shares at $58.75 per share.
Aaron Ondrey currently owns 128,173 shares of Mirati Therapeutics, Inc. (MRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aaron Ondrey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aaron Ondrey has 11 Form 4 filings on record as an insider at Mirati Therapeutics, Inc..
Set alerts for Aaron Ondrey and 40,000+ other insiders.